Jan 05, 2022
Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference
Corporate
Nov 02, 2021
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
Financial
Oct 27, 2021
Myriad Genetics to Release Third Quarter Financial Results on November 2, 2021
Financial
Aug 03, 2021
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
Financial
Jul 28, 2021
Myriad Genetics to Release Second Quarter Financial Results on August 3, 2021
Financial
May 24, 2021
Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to Q2 Solutions
Corporate
May 03, 2021
Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Financial
Feb 23, 2021
Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
Financial
Feb 16, 2021
Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021
Financial
Nov 09, 2020
Myriad Genetics Delivers 56% Sequential Increase in Quarterly Revenue; Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
Financial
Nov 04, 2020
Myriad Genetics to Announce Quarterly Financial Results on November 9, 2020
Financial
Aug 13, 2020
Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results
Financial
Aug 06, 2020
Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020
Corporate
May 05, 2020
Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results
Financial
Apr 28, 2020
Myriad to Announce Fiscal Third-Quarter 2020 Financial Results on May 5, 2020
Corporate